Yunxiao Zhang
Rongjiawan, 414006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Novel design of interleukin-2 derivatives with reversed pH and potent antitumor activity.
Journal: European journal of medicinal chemistry
Published: January 25, 2026
A Sequential Dual GLP-1R/GIPR Agonist-To-Antagonist Molecule Achieves Superior Weight Loss in Obese Mice.
Journal: Diabetes, obesity & metabolism
Published: January 17, 2026
Structural basis for inhibition of the voltage-gated sodium channel NaV1.7 by the tarantula toxin HWTX-I.
Journal: The Journal of biological chemistry
Published: November 07, 2025
Novel design of potent anti-tumour activity of IL-2 prodrug by FAPα-mediated activation.
Journal: International journal of biological macromolecules
Published: June 28, 2024
Optimizing Nav1.7-Targeted Analgesics: Revealing Off-Target Effects of Spider Venom-Derived Peptide Toxins and Engineering Strategies for Improvement.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 16, 2024
A two-step method preparation of semaglutide through solid-phase synthesis and inclusion body expression.
Journal: Protein expression and purification
Published: January 12, 2024
A novel ω-conotoxin Bu8 inhibiting N-type voltage-gated calcium channels displays potent analgesic activity.
Journal: Acta pharmaceutica Sinica. B
Published: December 21, 2020
Engineering of highly potent and selective HNTX-III mutant against hNav1.7 sodium channel for treatment of pain.
Journal: The Journal of biological chemistry
Published: October 17, 2020
Recombinant PaurTx-3, a spider toxin, inhibits sodium channels and decreases membrane excitability in DRG neurons.
Journal: Biochemical and biophysical research communications
Published: September 07, 2020
Naja atra venom peptide reduces pain by selectively blocking the voltage-gated sodium channel Nav1.8.
Journal: The Journal of biological chemistry
Published: December 31, 2018
Discovery of a Novel Nav1.7 Inhibitor From Cyriopagopus albostriatus Venom With Potent Analgesic Efficacy.
Journal: Frontiers in pharmacology
Published: July 12, 2018
Last Updated: 09/26/2026